Abstract CT073: Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038
Year: 2017
Type: conference-abstract
Source: Cancer Research
Authors: Antoni Ribas, Salvador Martín-Algarra, Shailender Bhatia, Wen-Jen Hwu, Craig L. Slingluff, William H. Sharfman, F. Stephen Hodi, Walter J. Urba, Jason J. Luke, John B. Haanen, Margaret K. Callahan, Jedd D. Wolchok, Scott D. Chasalow, Petra Ross-Macdonald, Tina C. Young, Anila Qureshi, Christine E. Horak
Institutions: Ronald Reagan UCLA Medical Center, Universidad de Navarra, University of Washington, The University of Texas MD Anderson Cancer Center, University of Virginia, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Dana-Farber Cancer Institute, University of Chicago, The Netherlands Cancer Institute, Memorial Sloan Kettering Cancer Center, Bristol-Myers Squibb (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2740839196